Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PharmaEssentia | Taiwan | Healthcare | Biotechnology & Medical Research | NT$232.69B | 125.3x | 0.43 | NT$699 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.9% Upside | Upgrade to Pro+ | |
Bora Pharmas | Taiwan | Healthcare | Pharmaceuticals | NT$88.25B | 22.2x | 0.71 | NT$854 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.9% Upside | Upgrade to Pro+ | |
Lotus Pharma | Taiwan | Healthcare | Pharmaceuticals | NT$73.78B | 16.8x | 1.49 | NT$278 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.9% Upside | Upgrade to Pro+ | |
Lumosa Therapeutics | TPEX | Healthcare | Biotechnology & Medical Research | NT$43.66B | -108.2x | NT$258.50 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -11% Downside | Upgrade to Pro+ | ||
Oneness Biotech | TPEX | Healthcare | Pharmaceuticals | NT$37.48B | -29.7x | -1.94 | NT$78.50 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Polaris Group | Taiwan | Healthcare | Biotechnology & Medical Research | NT$37.12B | -16.5x | 0.22 | NT$49.75 | 6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Center Laboratories | TPEX | Healthcare | Pharmaceuticals | NT$29.39B | -68.9x | -1.25 | NT$40.80 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pegavision | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$29.33B | 14.7x | 0.73 | NT$376 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12% Upside | Upgrade to Pro+ | |
EirGenix | TPEX | Healthcare | Pharmaceuticals | NT$25.57B | -25.9x | 0.44 | NT$83.50 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TaiMed Biologics | TPEX | Healthcare | Biotechnology & Medical Research | NT$24.60B | -167.5x | -8.63 | NT$90.10 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.1% Upside | Upgrade to Pro+ | |
TTY Biopharm | TPEX | Healthcare | Pharmaceuticals | NT$19.15B | 17.1x | -3.85 | NT$77 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.3% Upside | Upgrade to Pro+ | |
Universal Vision BioTech | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$18.47B | 17.1x | 4.26 | NT$218 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.4% Downside | Upgrade to Pro+ | |
SPT | Taiwan | Healthcare | Pharmaceuticals | NT$17.95B | 45x | 0.61 | NT$22.70 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.7% Upside | Upgrade to Pro+ | |
PharmaEngine | TPEX | Healthcare | Biotechnology & Medical Research | NT$17.31B | 46.7x | 1.72 | NT$120.50 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.4% Downside | Upgrade to Pro+ | |
Medigen Vaccine Biologics | TPEX | Healthcare | Pharmaceuticals | NT$16.86B | -26.3x | -0.52 | NT$51.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OBI Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$16.23B | -6.7x | 0.08 | NT$61.70 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tanvex BioPharma | Taiwan | Healthcare | Biotechnology & Medical Research | NT$15.88B | -6.1x | -0.28 | NT$66.70 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sunmax BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$14.92B | 21.4x | 1.05 | NT$274 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gongwin Biopharm | TPEX | Healthcare | Biotechnology & Medical Research | NT$14.75B | -133.1x | -3.57 | NT$116.50 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Y.S.H. | Taiwan | Healthcare | Pharmaceuticals | NT$14.73B | 14.3x | 0.31 | NT$55.30 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Synmosa Biopharma | TPEX | Healthcare | Pharmaceuticals | NT$14.27B | 19.9x | 1.15 | NT$33.95 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6% Upside | Upgrade to Pro+ | |
Excelsior | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$14.07B | 18.3x | 2.49 | NT$86.10 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.4% Downside | Upgrade to Pro+ | |
CHO Pharma | TPEX | Healthcare | Pharmaceuticals | NT$13.85B | -52.2x | -1.79 | NT$64.70 | -4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Taidoc Tech | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$13.69B | 15.4x | -0.49 | NT$143.50 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.5% Upside | Upgrade to Pro+ | |
Foresee Pharmas | TPEX | Healthcare | Biotechnology & Medical Research | NT$12.38B | -11.7x | -1.83 | NT$80 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lin Bio | TPEX | Healthcare | Pharmaceuticals | NT$11.40B | -15.3x | 0.48 | NT$145 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SCPC | Taiwan | Healthcare | Pharmaceuticals | NT$11.04B | 13x | NT$61.80 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.4% Upside | Upgrade to Pro+ | ||
Handa Pharmas | TPEX | Healthcare | Pharmaceuticals | NT$11B | 24x | -1.1 | NT$77.90 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ADIM | Taiwan | Healthcare | Pharmaceuticals | NT$10.56B | -17.4x | 0.07 | NT$25.05 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8.2% Downside | Upgrade to Pro+ | |
SCI Pharmtech | Taiwan | Healthcare | Pharmaceuticals | NT$10.28B | 21x | 1.28 | NT$86 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
St.Shine Optical | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$9.63B | 15.3x | 9.47 | NT$191 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34% Upside | Upgrade to Pro+ | |
Mycenax Biotech | TPEX | Healthcare | Biotechnology & Medical Research | NT$9.24B | -17.1x | -0.68 | NT$44.70 | 4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
United Orthopedic | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$9.23B | 19.9x | 1.36 | NT$95.70 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.7% Upside | Upgrade to Pro+ | |
Formosa Lab | Taiwan | Healthcare | Pharmaceuticals | NT$8.91B | 22.7x | 0.5 | NT$74.10 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SVBI | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$8.62B | 37.8x | 1.14 | NT$120 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.5% Upside | Upgrade to Pro+ | |
Bioteque | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$8.59B | 17.2x | 2.08 | NT$124 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CHC Healthcare | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$8.46B | 26x | 3.69 | NT$50.70 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.4% Downside | Upgrade to Pro+ | |
Taigen BioPharmas | TPEX | Healthcare | Pharmaceuticals | NT$8.40B | 49x | 0.24 | NT$11.70 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Orient Pharma | TPEX | Healthcare | Pharmaceuticals | NT$8.39B | 70.4x | 0.21 | NT$37.60 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Panion BF Biotech | Taiwan | Healthcare | Pharmaceuticals | NT$7.64B | 62.8x | 0.18 | NT$89.10 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.4% Upside | Upgrade to Pro+ | |
Easywell Biomedical | TPEX | Healthcare | Pharmaceuticals | NT$7.41B | -59.6x | -3.03 | NT$60.80 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Savior Lifetec | TPEX | Healthcare | Pharmaceuticals | NT$6.81B | 37.8x | 0.1 | NT$21.45 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Onyx Healthcare | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$6.78B | 37.1x | -1.18 | NT$175.50 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pacific Hospital Supply | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$6.77B | 16.4x | -1.95 | NT$93.20 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3% Upside | Upgrade to Pro+ | |
Hi-Clearance | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$6.41B | 17.3x | 20.37 | NT$144 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sinphar | Taiwan | Healthcare | Pharmaceuticals | NT$5.71B | 17.1x | 0.84 | NT$31.55 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.7% Downside | Upgrade to Pro+ | |
Icares Medicus | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$5.62B | 84.6x | -1.56 | NT$132 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intai Tech | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$5.54B | 26.1x | -0.59 | NT$111.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medigen BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$5.04B | -12.2x | -0.4 | NT$36.20 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bionet | TPEX | Healthcare | Biotechnology & Medical Research | NT$4.39B | 77.9x | -2.39 | NT$86.50 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |